6
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

6
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lidocaine Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-34I7582
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Lidocaine Injection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Lidocaine Injection Market Research Report 2025

Code: QYRE-Auto-34I7582
Report
July 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lidocaine Injection Market

The global market for Lidocaine Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Lidocaine injection is a local anesthetic. This means that it reduces sensation or pain in the area of the body where it is injected and does not affect other areas.
North American market for Lidocaine Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lidocaine Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Lidocaine Injection include Fresenius Kabi, Hikma, Pfizer, Amphastar, AuroMedics, Livealth Biopharma, Hameln Pharmaceuticals, AdvaCare Pharma, Actiza Pharmaceutical, JumpCan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lidocaine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lidocaine Injection.
The Lidocaine Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lidocaine Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lidocaine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lidocaine Injection Market Report

Report Metric Details
Report Name Lidocaine Injection Market
Segment by Type
  • 0.005
  • 0.01
  • 0.015
  • 0.02
Segment by Application
  • Hospital
  • Clinic
  • Recovery Center
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Fresenius Kabi, Hikma, Pfizer, Amphastar, AuroMedics, Livealth Biopharma, Hameln Pharmaceuticals, AdvaCare Pharma, Actiza Pharmaceutical, JumpCan, LongerPharm Group, Hainan Tianhuang Pharmacy, Yabao Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lidocaine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lidocaine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Lidocaine Injection Market report?

Ans: The main players in the Lidocaine Injection Market are Fresenius Kabi, Hikma, Pfizer, Amphastar, AuroMedics, Livealth Biopharma, Hameln Pharmaceuticals, AdvaCare Pharma, Actiza Pharmaceutical, JumpCan, LongerPharm Group, Hainan Tianhuang Pharmacy, Yabao Pharmaceutical

What are the Application segmentation covered in the Lidocaine Injection Market report?

Ans: The Applications covered in the Lidocaine Injection Market report are Hospital, Clinic, Recovery Center

What are the Type segmentation covered in the Lidocaine Injection Market report?

Ans: The Types covered in the Lidocaine Injection Market report are 0.005, 0.01, 0.015, 0.02

1 Lidocaine Injection Market Overview
1.1 Product Definition
1.2 Lidocaine Injection by Type
1.2.1 Global Lidocaine Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.005
1.2.3 0.01
1.2.4 0.015
1.2.5 0.02
1.3 Lidocaine Injection by Application
1.3.1 Global Lidocaine Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Recovery Center
1.4 Global Lidocaine Injection Market Size Estimates and Forecasts
1.4.1 Global Lidocaine Injection Revenue 2020-2031
1.4.2 Global Lidocaine Injection Sales 2020-2031
1.4.3 Global Lidocaine Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Lidocaine Injection Market Competition by Manufacturers
2.1 Global Lidocaine Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Lidocaine Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Lidocaine Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Lidocaine Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lidocaine Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lidocaine Injection, Product Type & Application
2.7 Global Key Manufacturers of Lidocaine Injection, Date of Enter into This Industry
2.8 Global Lidocaine Injection Market Competitive Situation and Trends
2.8.1 Global Lidocaine Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lidocaine Injection Players Market Share by Revenue
2.8.3 Global Lidocaine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lidocaine Injection Market Scenario by Region
3.1 Global Lidocaine Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Lidocaine Injection Sales by Region: 2020-2031
3.2.1 Global Lidocaine Injection Sales by Region: 2020-2025
3.2.2 Global Lidocaine Injection Sales by Region: 2026-2031
3.3 Global Lidocaine Injection Revenue by Region: 2020-2031
3.3.1 Global Lidocaine Injection Revenue by Region: 2020-2025
3.3.2 Global Lidocaine Injection Revenue by Region: 2026-2031
3.4 North America Lidocaine Injection Market Facts & Figures by Country
3.4.1 North America Lidocaine Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Lidocaine Injection Sales by Country (2020-2031)
3.4.3 North America Lidocaine Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Lidocaine Injection Market Facts & Figures by Country
3.5.1 Europe Lidocaine Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Lidocaine Injection Sales by Country (2020-2031)
3.5.3 Europe Lidocaine Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lidocaine Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Lidocaine Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Lidocaine Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Lidocaine Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Lidocaine Injection Market Facts & Figures by Country
3.7.1 Latin America Lidocaine Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Lidocaine Injection Sales by Country (2020-2031)
3.7.3 Latin America Lidocaine Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lidocaine Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Lidocaine Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Lidocaine Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Lidocaine Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lidocaine Injection Sales by Type (2020-2031)
4.1.1 Global Lidocaine Injection Sales by Type (2020-2025)
4.1.2 Global Lidocaine Injection Sales by Type (2026-2031)
4.1.3 Global Lidocaine Injection Sales Market Share by Type (2020-2031)
4.2 Global Lidocaine Injection Revenue by Type (2020-2031)
4.2.1 Global Lidocaine Injection Revenue by Type (2020-2025)
4.2.2 Global Lidocaine Injection Revenue by Type (2026-2031)
4.2.3 Global Lidocaine Injection Revenue Market Share by Type (2020-2031)
4.3 Global Lidocaine Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Lidocaine Injection Sales by Application (2020-2031)
5.1.1 Global Lidocaine Injection Sales by Application (2020-2025)
5.1.2 Global Lidocaine Injection Sales by Application (2026-2031)
5.1.3 Global Lidocaine Injection Sales Market Share by Application (2020-2031)
5.2 Global Lidocaine Injection Revenue by Application (2020-2031)
5.2.1 Global Lidocaine Injection Revenue by Application (2020-2025)
5.2.2 Global Lidocaine Injection Revenue by Application (2026-2031)
5.2.3 Global Lidocaine Injection Revenue Market Share by Application (2020-2031)
5.3 Global Lidocaine Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Fresenius Kabi
6.1.1 Fresenius Kabi Company Information
6.1.2 Fresenius Kabi Description and Business Overview
6.1.3 Fresenius Kabi Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Fresenius Kabi Lidocaine Injection Product Portfolio
6.1.5 Fresenius Kabi Recent Developments/Updates
6.2 Hikma
6.2.1 Hikma Company Information
6.2.2 Hikma Description and Business Overview
6.2.3 Hikma Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hikma Lidocaine Injection Product Portfolio
6.2.5 Hikma Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Lidocaine Injection Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Amphastar
6.4.1 Amphastar Company Information
6.4.2 Amphastar Description and Business Overview
6.4.3 Amphastar Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Amphastar Lidocaine Injection Product Portfolio
6.4.5 Amphastar Recent Developments/Updates
6.5 AuroMedics
6.5.1 AuroMedics Company Information
6.5.2 AuroMedics Description and Business Overview
6.5.3 AuroMedics Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AuroMedics Lidocaine Injection Product Portfolio
6.5.5 AuroMedics Recent Developments/Updates
6.6 Livealth Biopharma
6.6.1 Livealth Biopharma Company Information
6.6.2 Livealth Biopharma Description and Business Overview
6.6.3 Livealth Biopharma Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Livealth Biopharma Lidocaine Injection Product Portfolio
6.6.5 Livealth Biopharma Recent Developments/Updates
6.7 Hameln Pharmaceuticals
6.7.1 Hameln Pharmaceuticals Company Information
6.7.2 Hameln Pharmaceuticals Description and Business Overview
6.7.3 Hameln Pharmaceuticals Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hameln Pharmaceuticals Lidocaine Injection Product Portfolio
6.7.5 Hameln Pharmaceuticals Recent Developments/Updates
6.8 AdvaCare Pharma
6.8.1 AdvaCare Pharma Company Information
6.8.2 AdvaCare Pharma Description and Business Overview
6.8.3 AdvaCare Pharma Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AdvaCare Pharma Lidocaine Injection Product Portfolio
6.8.5 AdvaCare Pharma Recent Developments/Updates
6.9 Actiza Pharmaceutical
6.9.1 Actiza Pharmaceutical Company Information
6.9.2 Actiza Pharmaceutical Description and Business Overview
6.9.3 Actiza Pharmaceutical Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Actiza Pharmaceutical Lidocaine Injection Product Portfolio
6.9.5 Actiza Pharmaceutical Recent Developments/Updates
6.10 JumpCan
6.10.1 JumpCan Company Information
6.10.2 JumpCan Description and Business Overview
6.10.3 JumpCan Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 JumpCan Lidocaine Injection Product Portfolio
6.10.5 JumpCan Recent Developments/Updates
6.11 LongerPharm Group
6.11.1 LongerPharm Group Company Information
6.11.2 LongerPharm Group Description and Business Overview
6.11.3 LongerPharm Group Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LongerPharm Group Lidocaine Injection Product Portfolio
6.11.5 LongerPharm Group Recent Developments/Updates
6.12 Hainan Tianhuang Pharmacy
6.12.1 Hainan Tianhuang Pharmacy Company Information
6.12.2 Hainan Tianhuang Pharmacy Description and Business Overview
6.12.3 Hainan Tianhuang Pharmacy Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hainan Tianhuang Pharmacy Lidocaine Injection Product Portfolio
6.12.5 Hainan Tianhuang Pharmacy Recent Developments/Updates
6.13 Yabao Pharmaceutical
6.13.1 Yabao Pharmaceutical Company Information
6.13.2 Yabao Pharmaceutical Description and Business Overview
6.13.3 Yabao Pharmaceutical Lidocaine Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Yabao Pharmaceutical Lidocaine Injection Product Portfolio
6.13.5 Yabao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lidocaine Injection Industry Chain Analysis
7.2 Lidocaine Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lidocaine Injection Production Mode & Process Analysis
7.4 Lidocaine Injection Sales and Marketing
7.4.1 Lidocaine Injection Sales Channels
7.4.2 Lidocaine Injection Distributors
7.5 Lidocaine Injection Customer Analysis
8 Lidocaine Injection Market Dynamics
8.1 Lidocaine Injection Industry Trends
8.2 Lidocaine Injection Market Drivers
8.3 Lidocaine Injection Market Challenges
8.4 Lidocaine Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Lidocaine Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Lidocaine Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Lidocaine Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Lidocaine Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Lidocaine Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Lidocaine Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Lidocaine Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Lidocaine Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Lidocaine Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Lidocaine Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Lidocaine Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Lidocaine Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lidocaine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lidocaine Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lidocaine Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Lidocaine Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Lidocaine Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Lidocaine Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Lidocaine Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Lidocaine Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Lidocaine Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Lidocaine Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Lidocaine Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Lidocaine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Lidocaine Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Lidocaine Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Lidocaine Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Lidocaine Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Lidocaine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Lidocaine Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Lidocaine Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Lidocaine Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Lidocaine Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Lidocaine Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Lidocaine Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Lidocaine Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Lidocaine Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Lidocaine Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lidocaine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Lidocaine Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Lidocaine Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Lidocaine Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Lidocaine Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Lidocaine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Lidocaine Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Lidocaine Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Lidocaine Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Lidocaine Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Lidocaine Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Lidocaine Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Lidocaine Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Lidocaine Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Lidocaine Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Lidocaine Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Lidocaine Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Lidocaine Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Lidocaine Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Lidocaine Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Lidocaine Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Lidocaine Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Lidocaine Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Lidocaine Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Lidocaine Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Lidocaine Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Lidocaine Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Lidocaine Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Lidocaine Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Lidocaine Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Fresenius Kabi Company Information
 Table 71. Fresenius Kabi Description and Business Overview
 Table 72. Fresenius Kabi Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Fresenius Kabi Lidocaine Injection Product
 Table 74. Fresenius Kabi Recent Developments/Updates
 Table 75. Hikma Company Information
 Table 76. Hikma Description and Business Overview
 Table 77. Hikma Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Hikma Lidocaine Injection Product
 Table 79. Hikma Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Lidocaine Injection Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Amphastar Company Information
 Table 86. Amphastar Description and Business Overview
 Table 87. Amphastar Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Amphastar Lidocaine Injection Product
 Table 89. Amphastar Recent Developments/Updates
 Table 90. AuroMedics Company Information
 Table 91. AuroMedics Description and Business Overview
 Table 92. AuroMedics Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. AuroMedics Lidocaine Injection Product
 Table 94. AuroMedics Recent Developments/Updates
 Table 95. Livealth Biopharma Company Information
 Table 96. Livealth Biopharma Description and Business Overview
 Table 97. Livealth Biopharma Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Livealth Biopharma Lidocaine Injection Product
 Table 99. Livealth Biopharma Recent Developments/Updates
 Table 100. Hameln Pharmaceuticals Company Information
 Table 101. Hameln Pharmaceuticals Description and Business Overview
 Table 102. Hameln Pharmaceuticals Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hameln Pharmaceuticals Lidocaine Injection Product
 Table 104. Hameln Pharmaceuticals Recent Developments/Updates
 Table 105. AdvaCare Pharma Company Information
 Table 106. AdvaCare Pharma Description and Business Overview
 Table 107. AdvaCare Pharma Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. AdvaCare Pharma Lidocaine Injection Product
 Table 109. AdvaCare Pharma Recent Developments/Updates
 Table 110. Actiza Pharmaceutical Company Information
 Table 111. Actiza Pharmaceutical Description and Business Overview
 Table 112. Actiza Pharmaceutical Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Actiza Pharmaceutical Lidocaine Injection Product
 Table 114. Actiza Pharmaceutical Recent Developments/Updates
 Table 115. JumpCan Company Information
 Table 116. JumpCan Description and Business Overview
 Table 117. JumpCan Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. JumpCan Lidocaine Injection Product
 Table 119. JumpCan Recent Developments/Updates
 Table 120. LongerPharm Group Company Information
 Table 121. LongerPharm Group Description and Business Overview
 Table 122. LongerPharm Group Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. LongerPharm Group Lidocaine Injection Product
 Table 124. LongerPharm Group Recent Developments/Updates
 Table 125. Hainan Tianhuang Pharmacy Company Information
 Table 126. Hainan Tianhuang Pharmacy Description and Business Overview
 Table 127. Hainan Tianhuang Pharmacy Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Hainan Tianhuang Pharmacy Lidocaine Injection Product
 Table 129. Hainan Tianhuang Pharmacy Recent Developments/Updates
 Table 130. Yabao Pharmaceutical Company Information
 Table 131. Yabao Pharmaceutical Description and Business Overview
 Table 132. Yabao Pharmaceutical Lidocaine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Yabao Pharmaceutical Lidocaine Injection Product
 Table 134. Yabao Pharmaceutical Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Lidocaine Injection Distributors List
 Table 138. Lidocaine Injection Customers List
 Table 139. Lidocaine Injection Market Trends
 Table 140. Lidocaine Injection Market Drivers
 Table 141. Lidocaine Injection Market Challenges
 Table 142. Lidocaine Injection Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lidocaine Injection
 Figure 2. Global Lidocaine Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lidocaine Injection Market Share by Type: 2024 & 2031
 Figure 4. 0.005 Product Picture
 Figure 5. 0.01 Product Picture
 Figure 6. 0.015 Product Picture
 Figure 7. 0.02 Product Picture
 Figure 8. Global Lidocaine Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Lidocaine Injection Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Recovery Center
 Figure 13. Global Lidocaine Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Lidocaine Injection Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Lidocaine Injection Sales (2020-2031) & (K Units)
 Figure 16. Global Lidocaine Injection Average Price (US$/Unit) & (2020-2031)
 Figure 17. Lidocaine Injection Report Years Considered
 Figure 18. Lidocaine Injection Sales Share by Manufacturers in 2024
 Figure 19. Global Lidocaine Injection Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Lidocaine Injection Players: Market Share by Revenue in Lidocaine Injection in 2024
 Figure 21. Lidocaine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Lidocaine Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Lidocaine Injection Sales Market Share by Country (2020-2031)
 Figure 24. North America Lidocaine Injection Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Lidocaine Injection Sales Market Share by Country (2020-2031)
 Figure 28. Europe Lidocaine Injection Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Lidocaine Injection Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Lidocaine Injection Revenue Market Share by Region (2020-2031)
 Figure 36. China Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Lidocaine Injection Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Lidocaine Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Lidocaine Injection Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Lidocaine Injection Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Lidocaine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Lidocaine Injection by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Lidocaine Injection by Type (2020-2031)
 Figure 58. Global Lidocaine Injection Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Lidocaine Injection by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Lidocaine Injection by Application (2020-2031)
 Figure 61. Global Lidocaine Injection Price (US$/Unit) by Application (2020-2031)
 Figure 62. Lidocaine Injection Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart